2.15
price down icon2.71%   -0.06
after-market Dopo l'orario di chiusura: 2.15
loading
Precedente Chiudi:
$2.21
Aprire:
$2.21
Volume 24 ore:
480.74K
Relative Volume:
0.57
Capitalizzazione di mercato:
$103.86M
Reddito:
-
Utile/perdita netta:
$-97.22M
Rapporto P/E:
-1.558
EPS:
-1.38
Flusso di cassa netto:
$-82.44M
1 W Prestazione:
-9.66%
1M Prestazione:
-6.11%
6M Prestazione:
-19.78%
1 anno Prestazione:
-92.76%
Intervallo 1D:
Value
$2.12
$2.22
Intervallo di 1 settimana:
Value
$2.12
$2.39
Portata 52W:
Value
$1.15
$33.98

Cassava Sciences Inc Stock (SAVA) Company Profile

Name
Nome
Cassava Sciences Inc
Name
Telefono
512-501-2444
Name
Indirizzo
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Name
Dipendente
30
Name
Cinguettio
Name
Prossima data di guadagno
2025-08-08
Name
Ultimi documenti SEC
Name
SAVA's Discussions on Twitter

Confronta SAVA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SAVA
Cassava Sciences Inc
2.15 109.66M 0 -97.22M -82.44M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-26 Downgrade H.C. Wainwright Buy → Neutral
2024-10-08 Aggiornamento H.C. Wainwright Neutral → Buy
2024-07-01 Downgrade H.C. Wainwright Buy → Neutral
2022-11-16 Downgrade B. Riley Securities Buy → Neutral
2021-07-15 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-07-07 Reiterato Maxim Group Buy
2021-04-27 Iniziato B. Riley Securities Buy
2021-02-16 Reiterato H.C. Wainwright Buy
2020-10-23 Iniziato Cantor Fitzgerald Overweight
2020-09-23 Aggiornamento H.C. Wainwright Neutral → Buy
2020-05-18 Downgrade H.C. Wainwright Buy → Neutral
2020-05-15 Downgrade Maxim Group Buy → Hold
2020-01-10 Reiterato Maxim Group Buy
Mostra tutto

Cassava Sciences Inc Borsa (SAVA) Ultime notizie

pulisher
Sep 03, 2025

Analyzing Cassava Sciences Inc. Equity Warrant with risk reward ratio chartsIndex Update & Fast Entry High Yield Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of Cassava Sciences Inc. visualizedJuly 2025 Volume & Fast Gain Swing Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using portfolio simulators with Cassava Sciences Inc. included2025 Big Picture & High Conviction Buy Zone Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to recover losses in Cassava Sciences Inc. Equity Warrant stockJuly 2025 Volume & Capital Efficient Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will breakout in Cassava Sciences Inc. lead to full recoveryPortfolio Profit Report & Breakout Confirmation Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Cassava Sciences Inc. Equity Warrant stock risky to hold nowJuly 2025 Snapshot & Fast Gain Stock Trading Tips - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Will Cassava Sciences Inc. benefit from macro trendsJuly 2025 Outlook & AI Based Buy/Sell Signal Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to track smart money flows in Cassava Sciences Inc.July 2025 Gainers & Community Supported Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Cassava Sciences Inc. recover in the next quarterTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tick level data insight on Cassava Sciences Inc. volatilityJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast Cassava Sciences Inc. recoveryJuly 2025 Chart Watch & Risk Adjusted Buy and Sell Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s next for Cassava Sciences Inc. Equity Warrant stock priceExit Point & Fast Exit and Entry Trade Guides - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Key resistance and support levels for Cassava Sciences Inc. Equity WarrantMarket Risk Summary & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying big data sentiment scoring on Cassava Sciences Inc. Equity WarrantWeekly Risk Report & AI Powered Market Entry Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using Ichimoku Cloud for Cassava Sciences Inc. technicals2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

How moving averages guide Cassava Sciences Inc. tradingWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using AI based signals to follow Cassava Sciences Inc. Equity WarrantJuly 2025 Closing Moves & Smart Swing Trading Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Cassava Sciences Inc. Equity Warrant price bounce be sustainableJuly 2025 Decliners & Target Return Focused Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Analyzing net buyer seller activity in Cassava Sciences Inc. Equity Warrant2025 Trade Ideas & Weekly Top Performers Watchlists - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Why is Cassava Sciences Inc. Equity Warrant stock going downWeekly Trade Review & Risk Controlled Swing Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

NinjaOne, Astrotech, and Recurly among Austin companies adding key leadership roles - The Business Journals

Sep 02, 2025
pulisher
Sep 02, 2025

News impact scoring models applied to Cassava Sciences Inc.July 2025 Setups & Fast Entry High Yield Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What to expect from Cassava Sciences Inc. Equity Warrant in the next 30 daysPortfolio Growth Summary & Community Verified Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Evaluating Cassava Sciences Inc. with trendline analysisWeekly Stock Summary & Community Consensus Stock Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cassava Sciences Inc. Equity Warrant still worth holding after the dipJuly 2025 Recap & Capital Efficient Trade Techniques - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Combining price and volume data for Cassava Sciences Inc. Equity WarrantWeekly Profit Analysis & Reliable Breakout Stock Forecasts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Visual analytics tools that track Cassava Sciences Inc. performancePortfolio Value Report & Stepwise Trade Execution Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Why is Cassava Sciences Inc. stock going upJuly 2025 Review & Growth Focused Stock Reports - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Cassava Sciences Inc. stock trendline breakdownGap Down & Weekly Setup with High ROI Potential - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Price momentum metrics for Cassava Sciences Inc. explainedJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Using Python tools to backtest Cassava Sciences Inc. Equity Warrant strategies2025 Growth vs Value & Weekly Market Pulse Updates - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Detecting support and resistance levels for Cassava Sciences Inc. Equity WarrantWeekly Trade Analysis & Verified Momentum Stock Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How cyclical is Cassava Sciences Inc. Equity Warrant’s revenue streamJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Does Cassava Sciences Inc. Equity Warrant meet Warren Buffett’s criteriaQuarterly Trade Report & Technical Confirmation Trade Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

How to integrate Cassava Sciences Inc. into portfolio analysis tools2025 Institutional Moves & Fast Moving Market Watchlists - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Real time breakdown of Cassava Sciences Inc. Equity Warrant stock performanceSell Signal & AI Enhanced Trading Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cassava Sciences Inc. Equity Warrant stock showing strong momentumPortfolio Performance Report & Free Daily Entry Point Trade Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Can Cassava Sciences Inc. reach resistance levels soonJuly 2025 Patterns & AI Forecasted Entry and Exit Points - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Multi factor analysis applied to Cassava Sciences Inc.Earnings Growth Report & Stepwise Swing Trade Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Does Cassava Sciences Inc. have pricing power2025 Volume Leaders & Safe Entry Zone Tips - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Volume spikes in Cassava Sciences Inc. Equity Warrant stock – what they meanJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cassava Sciences Inc. stock bottoming outJuly 2025 Summary & Proven Capital Preservation Tips - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Volume spikes in Cassava Sciences Inc. stock – what they meanJuly 2025 News Drivers & Daily Profit Maximizing Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Analyzing drawdowns of Cassava Sciences Inc. with statistical toolsWeekly Market Summary & Weekly High Return Opportunities - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Chart based analysis of Cassava Sciences Inc. trends2025 Trading Recap & Low Risk High Win Rate Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Does Cassava Sciences Inc. show high probability of reboundWeekly Investment Summary & Fast Exit and Entry Strategy Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Cassava Sciences Inc. Equity Warrant recovery potential after sell offMarket Performance Report & Real-Time Buy Zone Alerts - Newser

Aug 31, 2025

Cassava Sciences Inc Azioni (SAVA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Cassava Sciences Inc Azioni (SAVA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Schoen Eric
Chief Financial Officer
Nov 29 '24
Option Exercise
1.18
50,000
59,000
71,300
Schoen Eric
Chief Financial Officer
Nov 29 '24
Sale
3.86
59,800
230,828
11,500
Schoen Eric
Chief Financial Officer
Nov 29 '24
Sale
3.82
2,000
7,640
0
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):